european end-to-end CDMO company, pharma services
LinkedIn Share

16th World Pharmaceutical Industry Congress

16th World Pharmaceutical Industry Congress | November 25-27, 2025 | Jachranka (POL)

Patrycja Szkudlarek will be the only representative from Mabion at the 16th World Pharmaceutical Industry Congress. In simple terms, she’s in charge of making sure all of our equipment and systems are properly “qualified” – that means everything is installed and working correctly, meets regulatory standards, and is consistently maintained in that state. Her team works with every department at Mabion to keep our production and lab equipment in validated condition and to ensure that all instruments are regularly calibrated on schedule.

Mabion is pleased to announce its participation in the 16th World Pharmaceutical Industry Congress, a premier international conference for the pharmaceutical sector scheduled for 25-27 November 2025 at the Warszawianka Hotel in Jachranka. The 16th Congress of the World of the Pharmaceutical Industry is an annual international meeting that brings together drug manufacturers, dietary supplement producers, and suppliers of raw materials, laboratory equipment, packaging, and other solutions for the pharma industry. This event is widely regarded as the most important gathering for the pharma industry in Poland, offering a rich program of expert seminars, exhibitions, and networking opportunities that attract industry leaders from across the country.

Representing Mabion at this year’s Congress will be Patrycja Szkudlarek, Head of the Qualification Department at Mabion. Patrycja is the sole Mabion delegate at the event, and she brings with her extensive expertise in qualification processes within the biotech and biopharma industry. In her role at Mabion, she oversees a dedicated qualification unit that works across all departments to ensure every piece of equipment remains in a qualified state and fully compliant with GMP requirements. Her team works with every department at Mabion to keep our manufacturing processes and analytical lab equipment in validated condition and to ensure that all instruments are regularly calibrated on schedule.

At the Congress, Patrycja Szkudlarek will share her insights in a presentation titled Qualification 24/7 – How Equipment Qualification Becomes a Continuous Process. Her talk will delve into the evolving approach to equipment qualification, which is no longer treated as a one-time activity culminating in a Performance Qualification (PQ) report, but rather as an ongoing process woven into the entire lifecycle of devices and installations. She will highlight how the newly revised EU GMP Annex 1 places significant emphasis on Quality Risk Management (QRM) and Contamination Control Strategy (CCS), requiring qualification documentation to remain current and to actively support day-to-day operational decisions.

Moreover, she will discuss how to implement a “living” qualification document within an organization, one that continuously evolves and serves not only auditors but also engineers, QA personnel, and maintenance teams in making informed decisions and sustaining a strong quality culture.

If you want to talk to Patrycja, mail to p.szkudlarek@mabion.eu.

More informations at the pharma congress website.

Contact us